Quipt Home Medical Corp. (QIPT) P/E Ratio History
Historical price-to-earnings valuation from 2010 to 2023
Loading P/E history...
QIPT Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Quipt Home Medical Corp. (QIPT) trades at a price-to-earnings ratio of -14.6x, with a stock price of $3.65 and trailing twelve-month earnings per share of $-0.25.
The current P/E is 111% below its 5-year average of 136.5x. Over the past five years, QIPT's P/E has ranged from a low of 0.8x to a high of 606.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, QIPT trades at a 165% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, QIPT trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our QIPT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
QIPT P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 27.5 | - | +53% | |
| $2B | 6.9Lowest | 0.67Best | +817%Best | |
| $1B | 67.8 | - | +103% | |
| $26B | 24.9 | - | +224% | |
| $17B | 30.5 | - | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
QIPT Historical P/E Data (2010–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Fri Jun 30 2023 00:00:00 GM | $5.34 | $0.01 | 606.8x | +344% |
| FY2023 Q2 | Fri Mar 31 2023 00:00:00 GM | $7.01 | $0.04 | 166.1x | +22% |
| FY2023 Q1 | Sat Dec 31 2022 00:00:00 GM | $4.71 | $0.20 | 23.2x | -83% |
| FY2022 Q4 | Fri Sep 30 2022 00:00:00 GM | $4.17 | $0.11 | 36.7x | -73% |
| FY2022 Q3 | $4.62 | $0.01 | 600.0x | +339% | |
| FY2022 Q2 | $4.39 | $0.19 | 22.8x | -83% | |
| FY2021 Q1 | $5.04 | $0.10 | 52.5x | -62% | |
| FY2020 Q4 | Wed Sep 30 2020 00:00:00 GM | $3.92 | $0.05 | 76.1x | -44% |
| FY2020 Q3 | $3.29 | $0.29 | 11.5x | -92% | |
| FY2018 Q1 | Sun Dec 31 2017 00:00:00 GM | $0.98 | $0.05 | 19.0x | -86% |
| FY2013 Q3 | Sun Jun 30 2013 00:00:00 GM | $0.30 | $0.01 | 22.9x | -83% |
| FY2010 Q4 | $0.69 | $0.89 | 0.8x | -99% |
Average P/E for displayed period: 136.5x
See QIPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QIPT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QIPT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQIPT — Frequently Asked Questions
Quick answers to the most common questions about buying QIPT stock.
Is QIPT stock overvalued or undervalued?
QIPT trades at -14.6x P/E, below its 5-year average of 136.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does QIPT's valuation compare to peers?
Quipt Home Medical Corp. P/E of -14.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is QIPT's PEG ratio?
QIPT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2010-2023.